Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-08 Sale | 2024-08-12 8:33 pm | Tempest Therapeutics Inc. | TPST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 787,999 | $1.2272 | $967,033 | 3,507,056 (Indirect Direct) | View |
| 2024-07-03 Purchase | 2024-07-08 4:15 pm | Tempest Therapeutics Inc. | TPST | Brady Stephen R President and CEO | 35,000 | $2.11 | $73,850 | 46,376 (Direct) | View |
| 2024-07-02 Purchase | 2024-07-03 7:35 pm | Tempest Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer | 4,672 | $2.13 | $9,951 | 9,573 (Direct) | View |
| 2024-06-28 Purchase | 2024-07-02 4:15 pm | Tempest Therapeutics Inc. | TPST | Trojanowski Justin Corporate Controller | 7,500 | $2.16 | $16,200 | 22,168 (Direct) | View |
| 2022-04-29 Purchase | 2022-05-03 5:49 pm | Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director 10% Owner | 2,118,644 | $2.36 | $5,000,000 | 4,295,055 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-13 Option Award | 2024-06-14 6:05 pm | N/A 2034-06-12 | Tempest Therapeutics Inc. | TPST | Pellizzari Christine A Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 6:05 pm | N/A 2034-06-12 | Tempest Therapeutics Inc. | TPST | NICHOL GEOFFREY Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 6:05 pm | N/A 2034-06-12 | Tempest Therapeutics Inc. | TPST | Simantov Ronit Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 6:05 pm | N/A 2034-06-12 | Tempest Therapeutics Inc. | TPST | RAAB MICHAEL Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 4:41 pm | N/A 2034-01-02 | Tempest Therapeutics Inc. | TPST | Brady Stephen R President and CEO | 250,000 | $0 | 250,000 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 4:40 pm | N/A 2034-01-02 | Tempest Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 4:39 pm | N/A 2034-01-02 | Tempest Therapeutics Inc. | TPST | Trojanowski Justin Principal Accounting Officer | 26,500 | $0 | 26,500 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 4:38 pm | N/A 2034-01-02 | Tempest Therapeutics Inc. | TPST | Maestas Nicholas VP of Strategy and Finance | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-10-11 Option Award | 2023-10-13 4:41 pm | N/A 2033-10-10 | Tempest Therapeutics Inc. | TPST | Brady Stephen R President and CEO | 725,000 | $0 | 725,000 (Direct) | View |
| 2023-10-11 Option Award | 2023-10-13 4:39 pm | N/A 2033-10-10 | Tempest Therapeutics Inc. | TPST | Trojanowski Justin Corporate Controller | 55,000 | $0 | 55,000 (Direct) | View |
| 2023-10-11 Option Award | 2023-10-13 4:39 pm | N/A 2033-10-10 | Tempest Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer | 325,000 | $0 | 325,000 (Direct) | View |
| 2023-10-11 Option Award | 2023-10-13 4:38 pm | N/A 2033-10-10 | Tempest Therapeutics Inc. | TPST | Maestas Nicholas VP of Strategy and Finance | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:53 pm | N/A 2033-06-14 | Tempest Therapeutics Inc. | TPST | RAAB MICHAEL Director | 8,200 | $0 | 8,200 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:50 pm | N/A 2033-06-14 | Tempest Therapeutics Inc. | TPST | NICHOL GEOFFREY Director | 8,200 | $0 | 8,200 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:48 pm | N/A 2033-06-14 | Tempest Therapeutics Inc. | TPST | Pellizzari Christine A Director | 8,200 | $0 | 8,200 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:46 pm | N/A 2033-06-14 | Tempest Therapeutics Inc. | TPST | Simantov Ronit Director | 8,200 | $0 | 8,200 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 8:02 pm | N/A 2033-01-02 | Tempest Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer | 69,700 | $0 | 69,700 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 8:01 pm | N/A 2033-01-02 | Tempest Therapeutics Inc. | TPST | Dubensky Thomas W. President | 102,700 | $0 | 102,700 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 8:00 pm | N/A 2033-01-02 | Tempest Therapeutics Inc. | TPST | Brady Stephen R Chief Executive Officer | 177,300 | $0 | 177,300 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 7:59 pm | N/A 2033-01-02 | Tempest Therapeutics Inc. | TPST | Maestas Nicholas VP of Strategy and Finance | 38,425 | $0 | 38,425 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 7:57 pm | N/A 2033-01-02 | Tempest Therapeutics Inc. | TPST | Trojanowski Justin Corporate Controller | 20,300 | $0 | 20,300 (Direct) | View |
| 2022-10-03 Option Award | 2022-10-04 08:01 am | N/A 2032-10-02 | Tempest Therapeutics Inc. | TPST | Trojanowski Justin Corporate Controller | 2,500 | $0 | 2,500 (Direct) | View |
Ownership | 2022-10-04 08:00 am | N/A 2032-06-26 | Tempest Therapeutics Inc. | TPST | Trojanowski Justin Corporate Controller | 0 | $0 | 15,000 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 4:38 pm | N/A 2032-06-20 | Tempest Therapeutics Inc. | TPST | Lorenzo Pierre Corporate Controller | 8,477 | $0 | 8,477 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 4:35 pm | N/A 2032-06-20 | Tempest Therapeutics Inc. | TPST | Maestas Nicholas VP of Strategy and Finance | 51,270 | $0 | 51,270 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 4:32 pm | N/A 2032-06-20 | Tempest Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer | 55,680 | $0 | 55,680 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 4:31 pm | N/A 2032-06-20 | Tempest Therapeutics Inc. | TPST | Dubensky Thomas W. President | 87,801 | $0 | 87,801 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 4:29 pm | N/A 2032-06-20 | Tempest Therapeutics Inc. | TPST | Brady Stephen R Chief Executive Officer | 173,533 | $0 | 173,533 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:17 pm | N/A 2032-06-16 | Tempest Therapeutics Inc. | TPST | Pellizzari Christine A Director | 3,500 | $0 | 3,500 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:16 pm | N/A 2032-06-16 | Tempest Therapeutics Inc. | TPST | NICHOL GEOFFREY Director | 3,500 | $0 | 3,500 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:13 pm | N/A 2032-06-16 | Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director | 3,500 | $0 | 3,500 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:11 pm | N/A 2032-06-16 | Tempest Therapeutics Inc. | TPST | Simantov Ronit Director | 3,500 | $0 | 3,500 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:09 pm | N/A 2032-06-16 | Tempest Therapeutics Inc. | TPST | RAAB MICHAEL Director | 3,500 | $0 | 3,500 (Direct) | View |
Ownership | 2022-05-03 5:07 pm | N/A N/A | Tempest Therapeutics Inc. | TPST | Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner | 0 | $0 | 2,118,644 (Direct) | View |